# EVONILE share price & delivery % — NSE

> EVONILE delivery % against its own history, 144 sessions of split-adjusted NSE prices since 2026, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/EVONILE

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## At a glance

- EVONILE closed at ₹1,520.4 on 13 Nov 2026, -4.35% on the day.
- Delivery was 54.8% of traded quantity on 13 Nov 2026, the 51st percentile of its own 144 sessions with a reading (20-session average 51.2%, 1-year average 53.2%).
- Market capitalisation is ₹3,754 crore, with no positive trailing earnings for a P/E.

## Key data

The latest session's trading figures.

| Field | Value |
| --- | --- |
| Session | 2026-11-13 |
| Close (INR) | 1,520.4 |
| Change on the day (%) | -4.35% |
| Open (INR) | 1,589.6 |
| Day low (INR) | 1,501.4 |
| Day high (INR) | 1,594.8 |
| VWAP (INR) | 1,534.66 |
| Traded value (INR crore) | 7.27 |
| 52-week low (INR) | — |
| 52-week high (INR) | — |
| From 52-week high (%) | — |
| RSI (14) | 34.29 |
| ATR (14) | 118.1 |
| SMA 20 (INR) | 1,752.62 |
| SMA 50 (INR) | 1,887.58 |
| SMA 200 (INR) | — |
| Volume (shares) | 47.4K |
| Average volume, 20 sessions (shares) | 48.7K |
| Volatility, 1 year annualised (%) | 64.68% |
| Relative volume (× 20-day average) | 0.97× |
| Turnover (INR crore) | 7.27 |
| Industry | Pharmaceuticals |
| Peers | DIVISLAB LAURUSLABS SUNPHARMA ACUTAAS SAILIFE DRREDDY |

## Delivery percentage

Delivery is the share of traded quantity taken to demat rather than squared off the same day, measured here against this stock's own history.

Over the last 20 sessions EVONILE settled 51.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.2%, so recent sessions are running 2.0 points lower than usual.

| Field | Value |
| --- | --- |
| Delivery, 2026-11-13 (%) | 54.83% |
| Delivery, 20-day average (%) | 51.18% |
| Delivery, 1-year average (%) | 53.21% |
| Delivery percentile against own history | 51st |
| Lowest 20-session average on record (%) | 12% |
| Highest 20-session average on record (%) | 89.35% |
| Sessions with a delivery reading | 144 |

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Performance

| Period | Price return (%) |
| --- | --- |
| 1 day | -4.35% |
| 1 week | -13.54% |
| 1 month | -23.53% |
| 3 months | -1.80% |
| 6 months | +27.30% |
| 1 year | — |

## Valuation and growth

P/E is blank when trailing earnings are negative or unfiled, never a misleading number.

| Field | Value |
| --- | --- |
| Market cap (INR crore) | 3,754 |
| Free-float market cap (INR crore) | — |
| P/E (TTM) | — (no positive trailing earnings) |
| EPS (TTM, INR, split-adjusted) | — |
| Revenue (TTM, INR crore) | — |
| Net profit (TTM, INR crore) | — |
| Net margin (TTM, %) | — |
| Other income (% of PBT, TTM) | — |
| P/B | — |
| ROE (%) | — |
| Debt / equity | — |
| Shares outstanding (split-adjusted) | — |
| Listed on NSE | 2026-04-20 |
| Revenue growth YoY (%) | — |
| Revenue growth QoQ (%) | — |
| Profit growth YoY (%) | — |
| Profit growth QoQ (%) | — |
| Interest cost growth YoY (%) | — |

## Insider trades

No promoter, director or KMP of EVONILE bought or sold in the open market in the last 90 days. No open-market promoter purchase is on record. From SEBI insider-trading disclosures, dated by the day NSE broadcast them, and counting open-market purchases and sales only. [How the insider figures are counted](https://patternsradar.com/learn/insider-trading.md).

## Results and dividend calendar

Dividend per share by Indian financial year (April to March), the last five:

| Financial year | Dividend per share (INR) |
| --- | --- |
| FY24 | ₹47.5 |
| FY23 | ₹10 |
| FY22 | ₹10 |

## Filings in the last 12 months

4 events from 2021 to 2026: capital action 1, dividend 3 on record; the [EVONILE full history](https://patternsradar.com/s/EVONILE/history.md) lists them all. Dated by the day the company broadcast the filing; the price move is close to close on the first session that could trade it.

| Date | Kind | Filing | Price move, first session after (%) | Source |
| --- | --- | --- | --- | --- |
| 2026-11-11 | rights | Rights 5:12 @ Premium Rs 855/- | -15.93% | — |

## About the instrument

| Field | Value |
| --- | --- |
| Name | EVONILE |
| Symbol | EVONILE |
| Kind | equity |
| ISIN | INE234A01025 |
| Series | EQ |
| Listed on NSE | 2026-04-20 |
| Price history from | 2026-04-20 |
| Latest session | 2026-11-13 |
| Sessions | 144 |
| Macro sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic industry | Pharmaceuticals |
| F&O | no |
| Liquidity rank (20-day turnover) | 1041 |

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset. The NSE classification is the latest snapshot; the history since August 2026 is the `classification` records dataset.

## More in Pharmaceuticals & Biotechnology

| Symbol | Name | Industry | Close (INR) | Change on the day (%) | Turnover, 20-day average (INR crore) |
| --- | --- | --- | --- | --- | --- |
| [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) | Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 11,442 | -0.37% | 873.1 |
| [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) | Laurus Labs Limited | Pharmaceuticals & Biotechnology | 2,424 | +1.00% | 586.7 |
| [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) | Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 1,880 | -0.27% | 416.5 |
| [ACUTAAS](https://patternsradar.com/s/ACUTAAS.md) | Acutaas Chemicals Limited | Pharmaceuticals & Biotechnology | 4,039.1 | +1.08% | 355.8 |
| [SAILIFE](https://patternsradar.com/s/SAILIFE.md) | Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 1,928.8 | +1.24% | 320 |
| [DRREDDY](https://patternsradar.com/s/DRREDDY.md) | Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 1,380 | -0.48% | 276.5 |
| [PPLPHARMA](https://patternsradar.com/s/PPLPHARMA.md) | Piramal Pharma Limited | Pharmaceuticals & Biotechnology | 244.54 | -0.22% | 271.2 |
| [GLENMARK](https://patternsradar.com/s/GLENMARK.md) | Glenmark Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 2,640 | -0.74% | 229.6 |
| [AUROPHARMA](https://patternsradar.com/s/AUROPHARMA.md) | Aurobindo Pharma Limited | Pharmaceuticals & Biotechnology | 1,823.2 | +0.89% | 216.8 |
| [MANKIND](https://patternsradar.com/s/MANKIND.md) | Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 2,640 | +0.05% | 199.4 |
| [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) | Zydus Lifesciences Limited | Pharmaceuticals & Biotechnology | 1,189.9 | -1.33% | 196 |
| [CIPLA](https://patternsradar.com/s/CIPLA.md) | Cipla Limited | Pharmaceuticals & Biotechnology | 1,391.8 | -1.17% | 192.7 |

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

## Full history

The [EVONILE full history](https://patternsradar.com/s/EVONILE/history.md) has every quarter on both reporting bases with every line item, margins and per-share figures; every shareholding filing; the price reaction to every result; every dividend; every filing on record; and the price by year.

The interactive chart is on the rendered page: https://patternsradar.com/s/EVONILE.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.